These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37137307)

  • 1. Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival.
    Hoi DM; Junker S; Junk L; Schwechel K; Fischel K; Podlesainski D; Hawkins PME; van Geelen L; Kaschani F; Leodolter J; Morreale FE; Kleine S; Guha S; Rumpel K; Schmiedel VM; Weinstabl H; Meinhart A; Payne RJ; Kaiser M; Hartl M; Boehmelt G; Kazmaier U; Kalscheuer R; Clausen T
    Cell; 2023 May; 186(10):2176-2192.e22. PubMed ID: 37137307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ClpC2 protects mycobacteria against a natural antibiotic targeting ClpC1-dependent protein degradation.
    Taylor G; Cui H; Leodolter J; Giese C; Weber-Ban E
    Commun Biol; 2023 Mar; 6(1):301. PubMed ID: 36944713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from
    Weinhäupl K; Brennich M; Kazmaier U; Lelievre J; Ballell L; Goldberg A; Schanda P; Fraga H
    J Biol Chem; 2018 Jun; 293(22):8379-8393. PubMed ID: 29632076
    [No Abstract]   [Full Text] [Related]  

  • 4. Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase.
    Schmitz KR; Sauer RT
    Mol Microbiol; 2014 Aug; 93(4):617-28. PubMed ID: 24976069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial peptide CyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1-ClpP1P2 protease.
    Taylor G; Frommherz Y; Katikaridis P; Layer D; Sinning I; Carroni M; Weber-Ban E; Mogk A
    J Biol Chem; 2022 Aug; 298(8):102202. PubMed ID: 35768046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease.
    Schmitt EK; Riwanto M; Sambandamurthy V; Roggo S; Miault C; Zwingelstein C; Krastel P; Noble C; Beer D; Rao SP; Au M; Niyomrattanakit P; Lim V; Zheng J; Jeffery D; Pethe K; Camacho LR
    Angew Chem Int Ed Engl; 2011 Jun; 50(26):5889-91. PubMed ID: 21563281
    [No Abstract]   [Full Text] [Related]  

  • 7. The key to unlock the Hsp100/Clp protein degradation machines of Mycobacterium.
    Molière N; Turgay K
    Mol Microbiol; 2014 Aug; 93(4):583-6. PubMed ID: 24979233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1.
    Leodolter J; Warweg J; Weber-Ban E
    PLoS One; 2015; 10(5):e0125345. PubMed ID: 25933022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.
    Wolf NM; Lee H; Choules MP; Pauli GF; Phansalkar R; Anderson JR; Gao W; Ren J; Santarsiero BD; Lee H; Cheng J; Jin YY; Ho NA; Duc NM; Suh JW; Abad-Zapatero C; Cho S
    ACS Infect Dis; 2019 Jun; 5(6):829-840. PubMed ID: 30990022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Acyldepsipeptides Stimulate the
    Reinhardt L; Thomy D; Lakemeyer M; Westermann LM; Ortega J; Sieber SA; Sass P; Brötz-Oesterhelt H
    mBio; 2022 Dec; 13(6):e0141322. PubMed ID: 36286522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazinamide triggers degradation of its target aspartate decarboxylase.
    Gopal P; Sarathy JP; Yee M; Ragunathan P; Shin J; Bhushan S; Zhu J; Akopian T; Kandror O; Lim TK; Gengenbacher M; Lin Q; Rubin EJ; Grüber G; Dick T
    Nat Commun; 2020 Apr; 11(1):1661. PubMed ID: 32245967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.
    Famulla K; Sass P; Malik I; Akopian T; Kandror O; Alber M; Hinzen B; Ruebsamen-Schaeff H; Kalscheuer R; Goldberg AL; Brötz-Oesterhelt H
    Mol Microbiol; 2016 Jul; 101(2):194-209. PubMed ID: 26919556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of action.
    Weinhäupl K; Gragera M; Bueno-Carrasco MT; Arranz R; Krandor O; Akopian T; Soares R; Rubin E; Felix J; Fraga H
    J Biol Chem; 2022 Nov; 298(11):102553. PubMed ID: 36208775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions.
    Wolf NM; Lee H; Zagal D; Nam JW; Oh DC; Lee H; Suh JW; Pauli GF; Cho S; Abad-Zapatero C
    Acta Crystallogr D Struct Biol; 2020 May; 76(Pt 5):458-471. PubMed ID: 32355042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the interactions between Mycobacterium tuberculosis caseinolytic protease C1 (ClpC1) and ecumicin.
    Jung IP; Ha NR; Kim AR; Kim SH; Yoon MY
    Int J Biol Macromol; 2017 Aug; 101():348-357. PubMed ID: 28342755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unfoldase ClpC1 of
    Lunge A; Gupta R; Choudhary E; Agarwal N
    J Biol Chem; 2020 Jul; 295(28):9455-9473. PubMed ID: 32409584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics, phylogenetics, and coexpression analyses indicate novel interactions in the plastid CLP chaperone-protease system.
    Rei Liao JY; Friso G; Forsythe ES; Michel EJS; Williams AM; Boguraev SS; Ponnala L; Sloan DB; van Wijk KJ
    J Biol Chem; 2022 Mar; 298(3):101609. PubMed ID: 35065075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
    Choules MP; Wolf NM; Lee H; Anderson JR; Grzelak EM; Wang Y; Ma R; Gao W; McAlpine JB; Jin YY; Cheng J; Lee H; Suh JW; Duc NM; Paik S; Choe JH; Jo EK; Chang CL; Lee JS; Jaki BU; Pauli GF; Franzblau SG; Cho S
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action.
    Bürstner N; Roggo S; Ostermann N; Blank J; Delmas C; Freuler F; Gerhartz B; Hinniger A; Hoepfner D; Liechty B; Mihalic M; Murphy J; Pistorius D; Rottmann M; Thomas JR; Schirle M; Schmitt EK
    Chembiochem; 2015 Nov; 16(17):2433-6. PubMed ID: 26472355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo.
    Gao W; Kim JY; Anderson JR; Akopian T; Hong S; Jin YY; Kandror O; Kim JW; Lee IA; Lee SY; McAlpine JB; Mulugeta S; Sunoqrot S; Wang Y; Yang SH; Yoon TM; Goldberg AL; Pauli GF; Suh JW; Franzblau SG; Cho S
    Antimicrob Agents Chemother; 2015 Feb; 59(2):880-9. PubMed ID: 25421483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.